Federal Register / Vol. 74, No. 136 / Friday, July 17, 2009 / Notices 34765 

Dated: July 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17053 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Heart, Lung, 

and Blood Institute Special Emphasis 

Panel, July 29, 2009, 8 a.m. to July 30, 

2009, 5 p.m., Ritz Carlton Hotel, 1150 

22nd Street, NW., Washington, DC, 

20037 which was published in the 

Federal Register on July 8, 2009, FRE9– 

16115. 

The meeting date was changed from 

July 29–30, 2009 to July 29, 2009. The 

meeting is closed to the public. 

Dated: July 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17051 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

A—Cancer Centers. 

Date: August 7, 2009. 

Time: 7:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Gail J. Bryant, MD, 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd, Room 8107, 

MSC 8328, Bethesda, MD 20892–8328, (301) 

402–0801, gb30t@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17049 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; AIDS P01. 

Date: August 12, 2009. 

Time: 9 a.m. to 12:01 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rm 8121, Rockville, 

MD 20852, (Telephone Conference Call) 

Contact Person: Olivia Bartlett, PhD, Chief, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8121, Bethesda, MD 20892–7405, 301/594– 

2501, op2t@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17046 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel. ARRA—Standardized 

Testing of Nanoparticles for Their Safety to 

Human Health. 

Date: July 21–22, 2009. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Chapel Hill Hotel, One 

Europa Drive, Chapel Hill, NC 27514. 

Contact Person: Sally Eckert-Tilotta, PhD, 

Scientific Review Officer, Nat. Institute of 

Environmental Health Sciences, Office of 

Program Operations, Scientific Review 

Branch, P.O. Box 12233, Research Triangle 

Park, NC 27709. (919) 541–1446. 

eckertt1@niehs.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel. ARRA Nanomaterials 

Competitive Supplement Review. 

Date: July 22, 2009. 

Time: 8 a.m. to 9 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Chapel Hill Hotel, One 

Europa Drive, Chapel Hill, NC 27514. 

Contact Person: Sally Eckert-Tilotta, PhD, 

Scientific Review Officer, Nat. Institute of 

Environmental Health Sciences, Office of 

mstockstill on DSKH9S0YB1PROD with NOTICES

34766 Federal Register / Vol. 74, No. 136 / Friday, July 17, 2009 / Notices 

Program Operations, Scientific Review 

Branch, P.O. Box 12233, Research Triangle 

Park, NC 27709. (919) 541–1446. 

eckertt1@niehs.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: July 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17044 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel. ARRA–RC2– 

SEP–9. 

Date: July 23, 2009. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20814. 

(Telephone Conference Call) 

Contact Person: Alicja L Markowska, PhD, 

DSC, Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

7201 Wisconsin Avenue, Suite 2C212, 

Bethesda, MD 20892, 301–496–9666, 

markowsa@nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel. ARRA–RC2– 

SEP–10. 

Date: August 5, 2009. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20814. 

(Telephone Conference Call). 

Contact Person: Alicja L Markowska, PhD, 

DSC, Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

7201 Wisconsin Avenue, Suite 2C212, 

Bethesda, MD 20892, 301–496–9666, 

markowsa@nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: July 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17041 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Environmental Health Sciences Special 

Emphasis Panel, July 30, 2009, 2 p.m. to 

July 30, 2009, 4:30 p.m., NIEHS/ 

National Institutes of Health, Keystone 

Building, 530 Davis Drive, Research 

Triangle Park, NC 27709 which was 

published in the Federal Register on 

July 2, 2009, FR E9–15689. 

The meeting date was changed from 

July 30, 2009 to August 12, 2009 and the 

meeting time was changed from 2 p.m. 

to 2:30 p.m. The meeting is closed to the 

public. 

Dated: July 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17039 Filed 7–16–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Use of CD47 Antibodies, 

Antisense Oligonucleotides, and Small 

Molecules To Treat Disease Affecting 

the Vascular System 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

part 404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in U.S. Provisional Patent 

Application No. 60/850,132, filed 

October 6, 2006, now abandoned (HHS 

Ref. No. E–227–2006/0–US–01); U.S. 

Provisional Patent Application No. 60/ 

864,153, filed November 02, 2006, now 

abandoned (HHS Ref. No. E–227–2006/ 

1–US–01); U.S. Provisional Patent 

Application No. 60/888,754, filed 

February 07, 2007, now abandoned 

(HHS Ref. No. E–227–2006/2–US–01); 

U.S. Provisional Patent Application No. 

60/910,549, filed April 06, 2007, now 

abandoned (HHS Ref. No. E–227–2006/ 

3–US–01); U.S. Provisional Patent 

Application No. 60/956,375, filed 

August 16, 2007, now abandoned (HHS 

Ref. No. E–227–2006/4–US–01); PCT 

Patent Application No. PCT/2007/ 

080647, filed October 5, 2007, now 

abandoned (HHS Ref. No. E–227–2006/ 

5–PCT–01); U.S. Patent Application No. 

12/444,364, filed October 5, 2007 (HHS 

Ref. No. E–227–2006/5–US–02); 

Canadian Patent Application (not yet 

determined) (HHS Ref. No. E–227–2006/ 

5–CA–03); Australian Patent 

Application No. 2007319576, filed 

October 5, 2007 (HHS Ref. No. E–227– 

2006/5–AU–04); and European Patent 

Application No. 07868382.8, filed 

October 5, 2007 (HHS Ref. No. E–227– 

2006/5–EP–05), all of which are entitled 

‘‘Prevention of Tissue Ischemia, Related 

Methods and Compositions’’, developed 

by Dr. David Roberts (NCI), Dr. Jeffrey 

Isenberg, and Dr. William Frazier. The 

patent rights in these inventions have 

been assigned to the United States of 

America. The prospective exclusive 

license territory may be ‘‘worldwide’’, 

and the field of use may be limited to: 

(1) ‘‘The use of antibodies including 

humanized antibodies reacting with 

CD47 or related antigens, precursors, or 

molecules, and isolated and/or 

recombinant fragments, and conjugates 

mstockstill on DSKH9S0YB1PROD with NOTICES